Bluebird Bio Financial Statements (BLUE)
|
|
|
|
Report date
|
|
|
18.02.2020 |
23.02.2021 |
04.03.2022 |
29.03.2023 |
13.09.2024 |
|
14.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
44.7 |
250.7 |
3.66 |
3.60 |
29.5 |
|
53.1 |
|
Operating Income, bln rub |
|
|
-812.1 |
-629.5 |
-590.9 |
-287.1 |
-244.3 |
|
-316.7 |
|
EBITDA, bln rub |
? |
|
-772.7 |
-553.6 |
-556.9 |
-215.6 |
-167.2 |
|
-128.2 |
|
Net profit, bln rub |
? |
|
-789.6 |
-618.7 |
-562.6 |
-266.6 |
-211.9 |
|
-300.5 |
|
|
OCF, bln rub |
? |
|
-564.4 |
-470.4 |
-635.6 |
-353.0 |
-235.0 |
|
-223.7 |
|
CAPEX, bln rub |
? |
|
76.3 |
29.0 |
23.0 |
13.2 |
9.06 |
|
7.33 |
|
FCF, bln rub |
? |
|
-640.6 |
-499.3 |
-658.6 |
-366.2 |
-244.1 |
|
-231.0 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
853.8 |
874.9 |
529.9 |
275.7 |
240.2 |
|
290.8 |
|
Cost of production, bln rub |
|
|
2.98 |
5.40 |
38.9 |
10.1 |
33.5 |
|
76.2 |
|
R&D, bln rub |
|
|
582.4 |
588.0 |
319.9 |
240.8 |
167.7 |
|
107.2 |
|
Interest expenses, bln rub |
|
|
34.8 |
0.000 |
0.000 |
6.32 |
16.4 |
|
16.1 |
|
|
Assets, bln rub |
|
|
1 727 |
1 781 |
593.8 |
554.9 |
619.2 |
|
465.1 |
|
Net Assets, bln rub |
? |
|
1 285 |
1 355 |
374.3 |
196.3 |
194.5 |
|
-5.79 |
|
Debt, bln rub |
|
|
191.0 |
193.0 |
89.6 |
281.4 |
330.3 |
|
368.4 |
|
Cash, bln rub |
|
|
1 238 |
1 274 |
396.6 |
181.7 |
221.8 |
|
70.7 |
|
Net debt, bln rub |
|
|
-1 047 |
-1 081 |
-307.0 |
99.6 |
108.6 |
|
297.8 |
|
|
Ordinary share price, rub |
|
|
56.8 |
28.0 |
9.99 |
6.92 |
1.38 |
|
3.07 |
|
Number of ordinary shares, mln |
|
|
55.2 |
62.2 |
68.9 |
78.6 |
109.8 |
|
193.9 |
|
|
Market cap, bln rub |
|
|
3 137 |
1 742 |
688 |
544 |
152 |
|
595 |
|
EV, bln rub |
? |
|
2 090 |
661 |
381 |
643 |
260 |
|
893 |
|
Book value, bln rub |
|
|
1 258 |
1 332 |
369 |
186 |
178 |
|
-21 |
|
|
EPS, rub |
? |
|
-14.3 |
-9.95 |
-8.16 |
-3.39 |
-1.93 |
|
-1.55 |
|
FCF/share, rub |
|
|
-11.6 |
-8.03 |
-9.56 |
-4.66 |
-2.22 |
|
-1.19 |
|
BV/share, rub |
|
|
22.8 |
21.4 |
5.35 |
2.36 |
1.62 |
|
-0.11 |
|
|
EBITDA margin, % |
? |
|
-1 730% |
-220.8% |
-15 208% |
-5 993% |
-566.7% |
|
-241.4% |
|
Net margin, % |
? |
|
-1 767% |
-246.8% |
-15 364% |
-7 411% |
-718.4% |
|
-565.7% |
|
FCF yield, % |
? |
|
-20.4% |
-28.7% |
-95.7% |
-67.3% |
-161.1% |
|
-38.8% |
|
ROE, % |
? |
|
-61.4% |
-45.7% |
-150.3% |
-135.8% |
-108.9% |
|
5 194% |
|
ROA, % |
? |
|
-45.7% |
-34.7% |
-94.8% |
-48.0% |
-34.2% |
|
-64.6% |
|
|
P/E |
? |
|
-3.97 |
-2.82 |
-1.22 |
-2.04 |
-0.72 |
|
-1.98 |
|
P/FCF |
|
|
-4.90 |
-3.49 |
-1.05 |
-1.49 |
-0.62 |
|
-2.58 |
|
P/S |
? |
|
70.2 |
6.95 |
188.0 |
151.2 |
5.14 |
|
11.2 |
|
P/BV |
? |
|
2.49 |
1.31 |
1.87 |
2.93 |
0.85 |
|
-28.1 |
|
EV/EBITDA |
? |
|
-2.70 |
-1.19 |
-0.68 |
-2.99 |
-1.56 |
|
-6.96 |
|
Debt/EBITDA |
|
|
1.35 |
1.95 |
0.55 |
-0.46 |
-0.65 |
|
-2.32 |
|
|
R&D/CAPEX, % |
|
|
763.8% |
2 028% |
1 391% |
1 823% |
1 851% |
|
1 463% |
|
|
CAPEX/Revenue, % |
|
|
170.7% |
11.6% |
628.2% |
367.2% |
30.7% |
|
13.8% |
|
| Bluebird Bio shareholders |
